Since both the RHC mutations of MC1R and the MGRN1–MC1R interaction decrease MC1R-dependent activation of the cAMP pathway, we hypothesized that the level of expression and/or the activity of MGRN1 may still have poorly characterized effects on key properties of melanocytes and melanoma cells. The gene discussed is MC1R; the disease is melanoma.